KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Retained Earnings (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Retained Earnings for 17 consecutive years, with -$27.0 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 100.29% to -$27.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$27.0 million through Dec 2025, down 100.29% year-over-year, with the annual reading at -$27.0 million for FY2025, 100.29% down from the prior year.
  • Retained Earnings hit -$27.0 million in Q4 2025 for Quest Diagnostics, up from -$40.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $9.7 billion in Q1 2021 to a low of -$40.0 million in Q3 2025.
  • Historically, Retained Earnings has averaged $4.0 billion across 5 years, with a median of -$11.5 million in 2021.
  • Biggest five-year swings in Retained Earnings: tumbled 138.46% in 2022 and later surged 66957.14% in 2024.
  • Year by year, Retained Earnings stood at -$14.0 million in 2021, then tumbled by 57.14% to -$22.0 million in 2022, then soared by 36.36% to -$14.0 million in 2023, then soared by 66957.14% to $9.4 billion in 2024, then plummeted by 100.29% to -$27.0 million in 2025.
  • Business Quant data shows Retained Earnings for DGX at -$27.0 million in Q4 2025, -$40.0 million in Q3 2025, and -$16.0 million in Q2 2025.